A new 'Blue Ribbon' prostate cancer solutions guidebook what surgeons don't tell their patients: More men are now choosing high tech radiation therapies for prostate cancer treatment rather than surgery. The most up-to-date and comprehensive book on the subject examines all currently available prostate cancer solutions treatments.
A late stage German ovarian cancer patient, who was given months to live, in 1987 was injected with a then-experimental bio tech drug. The monoclonal antibody was being used to track tumors in the ovarian cancer patients body. Instead, it may lead to a breakthrough treatment for ovarian cancer patients.